Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus

Antimicrobial Agents and Chemotherapy
Jennifer L KoehlB J Wilkinson

Abstract

The cell wall composition and autolytic properties of passage-selected glycopeptide-intermediate Staphylococcus aureus (GISA) isolates and their parent strains were studied in order to investigate the mechanism of decreased vancomycin susceptibility. GISA had relatively modest changes in peptidoglycan composition involving peptidoglycan interpeptide bridges and somewhat decreased cross-linking compared to that of parent strains. The cell wall phosphorus content of GISA strains was lower than that of susceptible parent strains, indicating somewhat lower wall teichoic acid levels in the GISA strains. Similar to whole cells, isolated crude cell walls retaining autolytic activity of GISA had drastically reduced autolytic activity compared to that of parent strains, and this arose early in the development of the GISA phenotype. This was due to an alteration in the autolytic enzymes of GISA as revealed by normal susceptibility of GISA-purified cell walls to parental strain autolysin extract and lower activity and altered peptidoglycan hydrolase activity profiles in GISA autolysin extracts compared to those of parent strains. Northern blot analysis indicated that expression of atl, the major autolysin gene, was significantly downregul...Continue Reading

References

Mar 1, 1992·Antimicrobial Agents and Chemotherapy·J E GustafsonB J Wilkinson
Jul 1, 1997·The Journal of Antimicrobial Chemotherapy·K HiramatsuF C Tenover
Jul 31, 1998·Archives of Microbiology·R Jenni, B Berger-Bächi
Sep 19, 1998·FEMS Microbiology Letters·M W QoronflehB J Wilkinson
Jun 26, 1999·The Journal of Biological Chemistry·K SieradzkiA Tomasz
Sep 7, 2000·Microbiology and Molecular Biology Reviews : MMBR·K Lewis
Apr 17, 2001·Antimicrobial Agents and Chemotherapy·M W ClimoG L Archer
Oct 27, 2001·The Journal of Antimicrobial Chemotherapy·S Boyle-VavraR S Daum
Jan 30, 2002·The Journal of Antimicrobial Chemotherapy·Matthew B AvisonTimothy R Walsh
Mar 2, 2002·The Lancet Infectious Diseases·K Hiramatsu
Oct 18, 2002·Antimicrobial Agents and Chemotherapy·Franziska SchaaffGabriele Bierbaum
Jan 9, 2003·Journal of Clinical Microbiology·Longzhu CuiKeiichi Hiramatsu
May 23, 2003·Antimicrobial Agents and Chemotherapy·Susan Boyle-VavraRobert S Daum
Jun 7, 2003·Molecular Microbiology·S S IngavaleA L Cheung
Jul 18, 2003·Journal of Bacteriology·Emmanuel MongodinGordon L Archer
Jul 18, 2003·Journal of Medical Microbiology·John E GustafsonBrian J Wilkinson
Jul 24, 2003·Trends in Microbiology·Kenneth W Bayles

❮ Previous
Next ❯

Citations

Apr 12, 2011·Medicina clínica·María Isabel Morosini, Rafael Cantón
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George SakoulasGeorge M Eliopoulos
Apr 5, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Yang SongBrian J Wilkinson
Jun 28, 2006·Antimicrobial Agents and Chemotherapy·N McCallumR Landmann
May 9, 2012·Antimicrobial Agents and Chemotherapy·Aneela Qamar, Dasantila Golemi-Kotra
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Caroline M Kusuma, John F Kokai-Kun
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Sugunya UtaidaB J Wilkinson
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·George SakoulasGeorge M Eliopoulos
Feb 4, 2009·Infection and Immunity·Katherine J LauderdaleAlexander R Horswill
May 20, 2009·BMC Microbiology·Kati SeidlBrigitte Berger-Bächi
Apr 20, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hui-Lin ZhaoBin-Bin Xie
Aug 12, 2014·The Journal of Antimicrobial Chemotherapy·Anne BerscheidGabriele Bierbaum
Dec 5, 2008·Expert Review of Anti-infective Therapy·Peter K Linden
Apr 19, 2010·Pharmaceuticals·Maria do Carmo de Freire BastosMarcus Lívio Varella Coelho
Feb 26, 2008·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Tomoko OshiroAriaki Nagayama
Sep 19, 2007·International Journal of Antimicrobial Agents·Ian M Gould
May 18, 2007·International Journal of Antimicrobial Agents·I M Gould
Dec 1, 2011·Environmental Microbiology Reports·Miriam MoscosoErnesto García
Jul 6, 2014·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·John J VarroneEdward M Schwarz
Jan 18, 2006·Biochemical Pharmacology·John L Pace, Guang Yang
Feb 24, 2006·Biochemical Pharmacology·Richard L Monaghan, John F Barrett
Sep 6, 2007·BMC Genomics·Judith HübscherBrigitte Berger-Bächi
Apr 10, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Benjamin P HowdenTimothy P Stinear
Oct 29, 2013·International Journal of Medical Microbiology : IJMM·Bernd HesslingDörte Becher
Mar 18, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J GarauS Harbarth
Aug 9, 2018·PloS One·Claes Søndergaard WassmannJanne Kudsk Klitgaard
Aug 27, 2014·Antimicrobial Agents and Chemotherapy·Dhritiman Samanta, Mohamed O Elasri

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.